Omentum ECM-based hydrogel as a platform for cardiac cell delivery

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Cardiovascular Research

Background:

• Cardiovascular diseases are a leading cause of death globally.
• Cardiac cell-based therapy shows promise but suffers from poor cell retention.
• Existing delivery systems face challenges with immune responses due to non-autologous materials.

Purpose of the Study:

• To develop an injectable, thermoresponsive, and autologous hydrogel for enhanced cardiac cell delivery.
• To create a biomaterial that improves cell retention and viability in the infarct area.
• To overcome immune rejection issues associated with allogeneic or xenogeneic extracellular matrix (ECM).

Main Methods:

• Development of an omentum-derived hydrogel capable of self-assembly under physiological conditions.
• Characterization of the hydrogel's biochemical composition, mechanical properties, gelation, and degradation kinetics.
• Evaluation of the hydrogel's capacity to encapsulate and support cardiac cell culture.

Main Results:

• The omentum-based hydrogel demonstrated self-assembly under physiological conditions.
• The biomaterial's composition, mechanical properties, and degradation profile were characterized.
• Successful encapsulation and support of cardiac cell viability within the hydrogel were confirmed.

Conclusions:

• An autologous omentum-based hydrogel was successfully developed as a cell delivery vehicle.
• This novel hydrogel platform shows potential for personalized cell delivery to cardiac and other tissues.
• The developed hydrogel addresses the challenge of poor cell retention in cardiac cell therapy.